Clinical significance of peritumoral lymphatic vessel density and lymphatic vessel invasion detected by D2-40 immunostaining in FIGO Ib1-IIa squamous cell cervical cancer

Cell and Tissue Research

Volumn 348, Issue 3, 2012, Pages 515-522

  Xiong, Ying ^a,b   Cao, Li Ping ^a,b   Rao, Hui Lan ^a,b   Cai, Mu Yan ^a,b   Liang, Li Zhi ^a   Liu, Ji Hong ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cervical cancer; D2 40; Human; Lymphatic vessel density; Lymphatic vessel invasion; Prognosis

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; M2A ANTIGEN; MONOCLONAL ANTIBODY D2-40; PARAFFIN; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; BLOOD VESSEL PARAMETERS; CANCER GRADING; CANCER INVASION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL DENSITY; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; PELVIS LYMPH NODE; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; RISK ASSESSMENT; TUMOR VOLUME; UNIVARIATE ANALYSIS; UTERINE CERVIX CARCINOMA;

ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC VESSELS; MIDDLE AGED; NEOPLASM INVASIVENESS; RECURRENCE; UTERINE CERVICAL NEOPLASMS;

EID: 84866319336     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-012-1384-x     Document Type: Article

References (27)

1. Balsat C, Blacher S, Signolle N, Beliard A, Munaut C, Goffin F, Noel A, Foidart JM, Kridelka F (2011) Whole slide quantification of stromal lymphatic vessel distribution and peritumoral lymphatic vessel density in early invasive cervical cancer: a method description. ISRN Obstet Gynecol 2011:354861
2. Birner P, Schindl M, Obermair A, Breitenecker G, Kowalski H, Oberhuber G (2001) Lymphatic microvessel density as a novel prognostic factor in early-stage invasive cervical cancer. Int J Cancer 95:29-33
3. Botting SK, Fouad H, Elwell K, Rampy BA, Salama SA, Freeman DH, Diaz-Arrastia CR (2010) Prognostic significance of peritumoral lymphatic vessel density and vascular endothelial growth factor receptor 3 in invasive squamous cell cervical cancer. Transl Oncol 3:170-175
4. Gombos Z, Xu X, Chu CS, Zhang PJ, Acs G (2005) Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix. Clin Cancer Res 11:8364-8371
5. Gupta GP, Massagué J (2006) Cancer metastasis: building a framework. Cell 127:679-695
6. Hirakawa S, Hong YK, Harvey N, Schacht V, Matsuda K, Libermann T, Detmar M (2003) Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells. Am J Pathol 162:575-586
7. Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF, Detmar M (2005) VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 201:1089-1099
8. Johnson LA, Prevo R, Clasper S, Jackson DG (2007) Inflammationinduced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1. J Biol Chem 282:33671-33680
9. Longatto-Filho A, Pinheiro C, Pereira SM, Etlinger D, MoreiraMA, Jubé LF, Queiroz GS, Baltazar F, Schmitt FC (2007) Lymphatic vessel density and epithelial D2-40 immunoreactivity in pre-invasive and invasive lesions of the uterine cervix. Gynecol Oncol 107:45-51
10. Mandriota SJ, Jussila L, Jeltsch M, Compagni A, Baetens D, Prevo R, Banerji S, Huarte J, Montesano R, Jackson DG, Orci L, Alitalo K, Christofori G, Pepper MS (2001) Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 20:672-682
11. Padera TP, Kadambi A, Tomaso E di, Carreira CM, Brown EB, Boucher Y, Choi NC, Mathisen D, Wain J, Mark EJ, Munn LL, Jain RK (2002) Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296:1883-1886
12. Partanen TA, Alitalo K, Miettinen M (1999) Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Cancer 86:2406-2412
13. Pepper MS, Tille JC, Nisato R, Skobe M (2003) Lymphangiogenesis and tumor metastasis. Cell Tissue Res 314:167-177
14. Roy S, Chu A, Trojanowski JQ, Zhang PJ (2005) D2-40, a novel monoclonal antibody against the M2A antigen as a marker to distinguish hemangioblastomas from renal cell carcinomas. Acta Neuropathol 109:497-502
15. Schoppmann SF, Schindl M, Breiteneder-Geleff S, Soleima A, Breitenecker G, Karner B, Birner P (2001) Inflammatory stromal reaction correlates with lymphaticmicrovessel density in early-stage cervival cancer. Anticancer Res 21:3419-3423
16. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmar M (2001) Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7:192-198
17. Sotiropoulou N, Bravou V, Kounelis S, Damaskou V, Papaspirou E, Papadaki H (2010) Tumour expression of lymphangiogenic growth factors but not lymphatic vessel density is implicated in human cervical cancer progression. Pathology 42:629-636
18. Stacker SA, Caesar C, Baldwin ME, Thornton GE, Williams RA, Prevo R, Jackson DG, Nishikawa S, Kubo H, Achen MG (2001) VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7:186-191
19. Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K (2002) Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2:573-583
20. Urabe A, Matsumoto T, Kimura M, Sonoue H, Kinoshita K (2006) Grading system of lymphatic invasion according to D2-40 immunostaining is useful for the prediction of nodal metastasis in squamous cell carcinoma of the uterine cervix. Histopathology 49:493-497
21. Van der Auwera I, Cao Y, Tille JC, Pepper MS, Jackson DG, Fox SB, Harris AL, Dirix LY, Vermeulen PB (2006) First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours. Br J Cancer 95:1611-1625
22. Van Trappen PO, Pepper MS (2002) Lymphatic dissemination of tumour cells and the formation of micrometastases. Lancet Oncol 3:44-52
23. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324:1-8
24. Yonemura Y, Endou Y, Tabachi K, Kawamura T, Yun HY, Kameya T, Hayashi I, Bandou E, Sasaki T, Miura M (2006) Evaluation of lymphatic invasion in primary gastric cancer by a new monoclonal antibody, D2-40. Hum Pathol 37:1193-1199
25. Zaganelli FL, Carvalho FM, Almeida BG, Bacchi CE, Goes JC, Calil MA, Baracat EC, Carvalho JP (2010) Intratumoral lymphatic vessel density and clinicopathologic features of patients with early-stage cervical cancer after radical hysterectomy. Int J Gynecol Cancer 20:1225-1231
26. Zhang JP, Lü WG, Chen HZ, Zhou CY, Xie X (2005) Tumor lymphangiogenesis in cervical squamous cell carcinoma and its clinical significance (in Chinese). JZhonghua Yi Xue Za Zhi 85:1551-1554
27. Zhang SQ, Yu H, Zhang LL (2009) Clinical implications of increased lymph vessel density in the lymphatic metastasis of early-stage invasive cervical carcinoma: a clinical immunohistochemical method study. BMC Cancer 9:64